Institut Pasteur, Université Paris Cité, CNRS UMR6047, Yersinia Research Unit, 28 rue du Dr Roux, 75015 Paris, France.
Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), 18 route du Panorama, 92260 Fontenay-aux-Roses, France.
FEMS Microbiol Rev. 2024 May 8;48(3). doi: 10.1093/femsre/fuae013.
Bloodstream infection is a major public health concern associated with high mortality and high healthcare costs worldwide. Bacteremia can trigger fatal sepsis whose prevention, diagnosis, and management have been recognized as a global health priority by the World Health Organization. Additionally, infection control is increasingly threatened by antimicrobial resistance, which is the focus of global action plans in the framework of a One Health response. In-depth knowledge of the infection process is needed to develop efficient preventive and therapeutic measures. The pathogenesis of bloodstream infection is a dynamic process resulting from the invasion of the vascular system by bacteria, which finely regulate their metabolic pathways and virulence factors to overcome the blood immune defenses and proliferate. In this review, we highlight our current understanding of determinants of bacterial survival and proliferation in the bloodstream and discuss their interactions with the molecular and cellular components of blood.
血流感染是一个主要的公共卫生关注点,与全球范围内的高死亡率和高医疗成本有关。菌血症可引发致命性败血症,其预防、诊断和管理已被世界卫生组织确认为全球卫生重点。此外,感染控制受到抗菌药物耐药性的日益威胁,这是在“同一健康”框架下全球行动计划的重点。为了制定有效的预防和治疗措施,需要深入了解感染过程。血流感染的发病机制是一个动态过程,源于细菌对血管系统的入侵,细菌通过精细调节其代谢途径和毒力因子来克服血液的免疫防御并增殖。在这篇综述中,我们强调了我们对细菌在血液中存活和增殖决定因素的现有理解,并讨论了它们与血液的分子和细胞成分的相互作用。